Citadel Advisors
PROF

Citadel Advisors’s Profound Medical PROF Stock Holding History

Citadel Advisors’s Portfolio PROF Stock Details PROF Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$85.5K Buy
+13,200
New +$91.2K ﹤0.01% 12134
2025
Q2 		– Sell
-3,300
Closed -$19.2K – 14537
2025
Q1 		$19.2K Sell
3,300
-600
-15% -$4.14K ﹤0.01% 13174
2024
Q4 		$29.3K Buy
3,900
+2,700
+225% +$20.7K ﹤0.01% 12895
2024
Q3 		$9.55K Buy
+1,200
New +$10.8K ﹤0.01% 13249
2024
Q2 		– Sell
-7,900
Closed -$67.4K – 15138
2024
Q1 		$67.4K Buy
7,900
+100
+1% +$835 ﹤0.01% 11866
2023
Q4 		$66.2K Sell
7,800
-7,600
-49% -$72.2K ﹤0.01% 11463
2023
Q3 		$157K Buy
15,400
+600
+4% +$6.22K ﹤0.01% 10286
2023
Q2 		$193K Hold
14,800
– – ﹤0.01% 9953
2023
Q1 		$137K Buy
14,800
+8,200
+124% +$94.9K ﹤0.01% 10782
2022
Q4 		$71.9K Sell
6,600
-48,600
-88% -$265K ﹤0.01% 11674
2022
Q3 		$223K Buy
55,200
+2,100
+4% +$14.2K ﹤0.01% 10189
2022
Q2 		$387K Buy
53,100
+800
+2% +$6.33K ﹤0.01% 9213
2022
Q1 		$471K Sell
52,300
-12,000
-19% -$116K ﹤0.01% 9535
2021
Q4 		$722K Sell
64,300
-26,900
-29% -$336K ﹤0.01% 8761
2021
Q3 		$1.33M Buy
91,200
+46,000
+102% +$701K ﹤0.01% 7400
2021
Q2 		$739K Sell
45,200
-12,400
-22% -$231K ﹤0.01% 9131
2021
Q1 		$1.16M Buy
57,600
+32,300
+128% +$775K ﹤0.01% 7742
2020
Q4 		$520K Buy
+25,300
New +$465K ﹤0.01% 8079

Other funds holding PROF

Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return
GS
Gagnon Securities New York $433M AUM 29.08% 1-Year Est. Return
TIM
Timelo Investment Management Aurora, Ontario, Canada $127M AUM 23.73% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
GA
Gagnon Advisors New York $136M AUM 21.55% 1-Year Est. Return
LBA
Letko, Brosseau & Associates Montreal, Quebec, Canada $6.2B AUM 38.92% 1-Year Est. Return
RA
Rosalind Advisors Toronto, Ontario, Canada $249M AUM 80.12% 1-Year Est. Return
ZCP
Z3 Capital Partners Richmond, Virginia $395M AUM
MI
MMCAP International Grand Cayman, Cayman Islands $1.16B AUM 77.9% 1-Year Est. Return
AAP
Ardsley Advisory Partners Stamford, Connecticut $960M AUM 207.76% 1-Year Est. Return

Citadel Advisors's PROF Position: Q4 2025 in Review

Citadel Advisors sold out of Profound Medical (PROF) in Q4 2025, closing a stake of 10,073 shares — an estimated $50.2K sold.

Citadel Advisors first reported a position in PROF in Q1 2020 and held it in 16 quarters. The position peaked at $1.65M in Q1 2021. 63 funds tracked by Wall St. Rank hold PROF as of Q4 2025.

  • Citadel Advisors reported no remaining Profound Medical position as of Q4 2025 after selling out during the quarter.
  • Citadel Advisors sold 10,073 Profound Medical shares in Q4 2025, an estimated $50.2K.
  • Citadel Advisors first reported a position in Profound Medical in Q1 2020 and held it in 16 quarters.
  • Citadel Advisors's Profound Medical position peaked at $1.65M in Q1 2021.
  • 63 funds tracked by Wall St. Rank held Profound Medical as of Q4 2025.

Based on Citadel Advisors's 13F filing for Q4 2025, filed 17 Feb 2026.